SEARCH

SEARCH BY CITATION

References

  • 1
    Ansell J, Hirsh J, Hylek E et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008;133:160S198S.
  • 2
    Holbrook AM, Pereira JA, Labiris R et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med, 2005;165:10951106.
  • 3
    Kramer P, McClain CJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med, 1981;305:12621264.
  • 4
    Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther, 1985;37:396401.
  • 5
    Kramer P, Tsuru M, Cook CE, McClain CJ, Holtzman JL. Effect of influenza vaccine on warfarin anticoagulation. Clin Pharmacol Ther, 1984;35:416418.
  • 6
    Lipsky BA, Pecoraro RE, Roben NJ, de Blaquiere P, Delaney CJ. Influenza vaccination and warfarin anticoagulation. Ann Intern Med, 1984;100:835837.
  • 7
    Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc, 1985;33:269272.
  • 8
    Gomolin IH. Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly. Can Med Assoc J, 1986;135:3941.
  • 9
    Weibert RT, Lorentz SM, Norcross WA, Klauber MR, Jagger PI. Effect of influenza vaccine in patients receiving long-term warfarin therapy. Clin Pharm, 1986;5:499503.
  • 10
    Bussey HI, Saklad JJ. Effect of influenza vaccine on chronic warfarin therapy. Drug Intell Clin Pharm, 1988;21:198201.
  • 11
    Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med, 1995;155:15291531.
  • 12
    Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 “negative” trials. N Engl J Med, 1978;299:690694.
  • 13
    Hirsh J, Bates SM. Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective. Ann Intern Med, 2001;134:409417.
  • 14
    Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004;126(3 Suppl):204S233S.
  • 15
    Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep, 2010;59:162.
  • 16
    MacCallum P, Madhani M, Mt-Isa S, Ashby D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin. Pharmacoepidemiol Drug Saf, 2007;16:786789.
  • 17
    Paliani U, Filippucci E, Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001–2002. Haematologica 2003;88:599600.
  • 18
    Poli D, Chiarugi L, Capanni M et al. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis, 2002;13:297300.
  • 19
    Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA; for the Vaccine Safety Datalink investigators. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf, 2007;16:790796.
  • 20
    Iorio A, Basileo M, Marcucci M et al. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. Arch Intern Med, 2010;170:609616.
  • 21
    Farrow PR, Nicholson KG. Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin. J Infect, 1984;9:157160.
  • 22
    Arnold WSG, Mehta MK, Roberts JS. Influenza vaccine and anticoagulation control in patients receiving warfarin. Br J Clin Pract, 1990;44:136139.
  • 23
    Guillemin F. Primer: the fallacy of subgroup analysis. Nat Clin Pract Rheumatol, 2007;3:407413.
  • 24
    Delafuente JC, Davis JA, Meuleman JR, Jones RA. Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men. Pharmacotherapy, 1998;18:631636.
  • 25
    Casajuana J, Iglesias B, Fàbregas M et al. Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial. BMC Blood Disord, 2008;8:1.